Neuropathic pain resulting from spinal hemisection or selective spinal nerve ligation is characterized by an increase in membrane-bound tumor necrosis factor-alpha (mTNFa) in spinal microglia without detectable release of soluble TNFa (sTNFa). In tissue culture, we showed that a full-length transmembrane cleavage-resistant TNFa (CRTNFa) construct can act through cell-cell contact to activate neighboring microglia. We undertook the current study to test the hypothesis that mTNFa expressed in microglia might also affect the phenotype of primary sensory afferents, by determining the effect of CRTNFa expressed from COS-7 cells on gene expression in primary dorsal root ganglia (DRG) neurons. Co-culture of DRG neurons with CRTNFa-expressing COS-7 cells resulted in a significant increase in the expression of voltage-gated sodium channel isoforms Na V 1.7 and Na V 1.8, and voltage-gated calcium channel subunit Ca V 3.2 at both mRNA and protein levels, and enhanced CCL2 expression and release from the DRG neurons. Exposure to sTNFa produced an increase only in CCL2 expression and release. Treatment of the cells with an siRNA against tumor necrosis factor receptor 2 (TNFR2) significantly reduced CRTNFa-induced gene expression changes in DRG neurons, whereas administration of CCR2 inhibitor had no significant effect on CRTNFa-induced increase in gene expression and CCL2 release in DRG neurons. Taken together, the results of this study suggest that mTNFa expressed in spinal microglia can facilitate pain signaling by up-regulating the expression of cation channels and CCL2 in DRG neurons in a TNFR2-dependent manner.
Introduction
Tumor necrosis factor-alpha (TNFa) is a member of the superfamily of type II transmembrane proteins that is expressed in a full-length membrane-bound form (mTNFa) that can be cleaved by the inducible TNFa converting enzyme (TACE) to release the diffusible peptide soluble TNFa (sTNFa) [12] . Animal models of neuropathic pain are characterized by neuroimmune activation in the spinal cord associated with increased expression of TNFa in spinal microglia [6, 17, 19] . We previously observed, in models both of neuropathic pain resulting from spinal hemisection and after spinal nerve ligation, that the increase in TNFa mRNA is accompanied by an increase in mTNFa expression without a detectable release of sTNFa in the spinal cord [10, 18] In a subsequent study, we found that exposure of microglia to substance P (SP) increases the expression of mTNFa without any increase in expression of TACE, and without release of sTNFa. Co-culture of COS-7 cells expressing a mutant TNFa resistant to cleavage by TACE (CRTNFa) with microglial cells led to microglial cell activation through direct cell-cell contact [26] . These results suggested a novel pathway through which release of SP by primary afferents activates microglial expression of mTNFa, establishing a feed-forward loop in glia that might contribute to the establishment of chronic pain.
To explore whether microglial expression of mTNFa might also affect the phenotype of primary afferents, in the current study we used co-culture of COS-7 cells expressing CRTNFa with primary dorsal root ganglion (DRG) neurons in vitro to determine the effect of CRTNFa on the expression of genes the products of which are implicated in the pathogenesis of chronic neuropathic pain: the cation channel isoforms Na V 1.7 Na V 1.8, Ca V 3.2, and CCL2 [3,5,14,15,22,23]. We found that co-culture of DRG neurons with CRTNFa-expressing COS-7 cells, but not exposure of the neurons to sTNFa, resulted in an increase in the expression of the voltagegated sodium channel isoforms Na V 1.7 and Na V 1.8, and the voltage-gated calcium channel isoform Ca V 3.2. Knockdown of the
